For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Optimising the benefits of oral anticoagulants for atrial fibrillation
+Practice
In print
Heartbeat
Optimising the benefits of oral anticoagulants for atrial fibrillation
Wednesday 7 June 2023, 12:25 AM

[Image: Supplied]
Oral anticoagulation reduces the rate of thromboembolism in patients with atrial fibrillation. Here, consultant cardiologist Chris Ellis reviews the importance of regular follow-up
This Practice article has been endorsed by the RNZCGP and has been approved for up to 0.25 credits for continuing professional development purposes (1, Educate small, BACK panel - grey
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
1. Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 2009;361(12):1139–51.
2. Harper P, Chang A, Stephens M. The changing use of anticoagulants in New Zealand. NZ Med J 2022;135(1554):35–43.